• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚一家三级医院中适合植入式心脏复律除颤器 (ICD) 但未植入的相关因素。

Factors Associated With Non-Uptake of Implantable Cardioverter-Defibrillator (ICD) Among Eligible Patients at a Tertiary Hospital in Kenya.

机构信息

Department of Internal Medicine, Aga Khan University, Nairobi, Kenya.

Brain and Mind Institute, Aga Khan University, Nairobi, Kenya.

出版信息

Glob Heart. 2024 Aug 16;19(1):66. doi: 10.5334/gh.1346. eCollection 2024.

DOI:10.5334/gh.1346
PMID:39157210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11328684/
Abstract

BACKGROUND

Efficacy of Implantable Cardioverter-Defibrillator (ICD) implantation in both primary and secondary prevention of Sudden Cardiac Death (SCD) in at-risk population is well established. ICD implantation rates remain low particularly in Africa with a paucity of data regarding factors associated with non-uptake.

OBJECTIVES

The primary study objective was to determine the factors associated with non-uptake of ICD among heart failure (HF) patients with reduced ejection fraction (EF<35%). Reasons for ICD refusal among eligible patients were reviewed as a secondary objective.

METHODS

This was a retrospective study among HF patients eligible for ICD implantation evaluated between 2018 to 2020. Comparison between ICD recipient and non-recipient categories was made to establish determinants of non-uptake.

RESULTS

Of 206 eligible patients, only 69 (33.5%) had an ICD. Factors independently associated with non-uptake were lack of private insurance (42.3% vs 63.8%; p = 0.005), non-cardiology physician (16.1% vs 5.8%; p = 0.045) and non-ischemic cardiomyopathy (54.7% vs 36.4% p = 0.014). The most common (75%) reason for ICD refusal was inability to pay for the device.

CONCLUSION

ICDs are underutilized among eligible HF with reduced EF patients in Kenya. The majority of patients without ICD had no private insurance, had non-ischemic cardiomyopathy and non-cardiology primary physician. Early referral of HF with reduced EF patients to HF specialists to optimize guideline-directed medical therapy and make ICD recommendation is needed.

摘要

背景

植入式心脏复律除颤器(ICD)在高危人群中的一级和二级预防心源性猝死(SCD)中的疗效已得到充分证实。ICD 的植入率仍然很低,尤其是在非洲,关于与未接受 ICD 治疗相关的因素的数据很少。

目的

本研究的主要目的是确定射血分数降低(EF<35%)心力衰竭(HF)患者中与 ICD 不接受相关的因素。作为次要目的,回顾了符合条件的患者拒绝 ICD 的原因。

方法

这是一项对 2018 年至 2020 年间符合 ICD 植入条件的 HF 患者进行的回顾性研究。对 ICD 接受者和非接受者类别进行比较,以确定不接受 ICD 的决定因素。

结果

在 206 名符合条件的患者中,仅有 69 名(33.5%)接受了 ICD。与 ICD 不接受相关的独立因素包括缺乏私人保险(42.3% vs 63.8%;p=0.005)、非心脏病学医师(16.1% vs 5.8%;p=0.045)和非缺血性心肌病(54.7% vs 36.4%;p=0.014)。拒绝植入 ICD 的最常见(75%)原因是无力支付设备费用。

结论

在肯尼亚,射血分数降低的 HF 患者中 ICD 的使用率较低。没有 ICD 的大多数患者没有私人保险,患有非缺血性心肌病和非心脏病学的初级医师。需要将射血分数降低的 HF 患者尽早转介给 HF 专家,以优化指南导向的药物治疗并提出 ICD 建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bbe/11328684/45c0301dd4c4/gh-19-1-1346-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bbe/11328684/45c0301dd4c4/gh-19-1-1346-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bbe/11328684/45c0301dd4c4/gh-19-1-1346-g1.jpg

相似文献

1
Factors Associated With Non-Uptake of Implantable Cardioverter-Defibrillator (ICD) Among Eligible Patients at a Tertiary Hospital in Kenya.肯尼亚一家三级医院中适合植入式心脏复律除颤器 (ICD) 但未植入的相关因素。
Glob Heart. 2024 Aug 16;19(1):66. doi: 10.5334/gh.1346. eCollection 2024.
2
Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.植入式心脏复律除颤器在射血分数降低和糖尿病的心力衰竭患者中的应用。
Eur J Heart Fail. 2018 Jun;20(6):1031-1038. doi: 10.1002/ejhf.1192. Epub 2018 May 15.
3
Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure.亚洲心力衰竭患者植入式心脏复律除颤器的适应证与实际应用之间的差异
Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11). doi: 10.1161/CIRCOUTCOMES.116.003651.
4
Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators.适合进行筛查检查及植入一级预防植入式心脏复律除颤器的患者所面临的障碍。
Europace. 2014 Nov;16(11):1575-9. doi: 10.1093/europace/euu054. Epub 2014 Mar 25.
5
Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.用于心脏性猝死一级预防的植入式心脏复律除颤器发生器更换后的结局
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):e003283. doi: 10.1161/CIRCEP.115.003283.
6
Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.老年晚期心力衰竭患者植入式心脏复律除颤器的围术期风险和生存情况。
JAMA Cardiol. 2020 Jun 1;5(6):643-651. doi: 10.1001/jamacardio.2020.0391.
7
Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.心力衰竭且射血分数降低患者植入式心脏复律除颤器植入用于心脏性猝死一级预防的患者障碍。
Singapore Med J. 2016 Apr;57(4):182-7. doi: 10.11622/smedj.2016072.
8
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.植入式心脏复律除颤器。预防性应用:基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.
9
Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region.用于心脏性猝死一级预防的植入式心脏复律除颤器的使用率:2012年对中西部一个健康转诊地区的计算
Heart Rhythm. 2014 May;11(5):849-55. doi: 10.1016/j.hrthm.2014.02.019. Epub 2014 Feb 22.
10
Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Heart Failure Patients With Diabetes Mellitus.老年心力衰竭合并糖尿病患者初级预防型植入式心脏转复除颤器的比较效果。
J Am Heart Assoc. 2020 Jun 16;9(12):e012405. doi: 10.1161/JAHA.119.012405. Epub 2020 May 30.

本文引用的文献

1
Clinical and Hospital Factors Affecting Treatment with Primary Prevention Implantable Cardioverter-Defibrillators in Ischemic Cardiomyopathy Patients.临床和医院因素对缺血性心肌病患者采用一级预防埋藏式心脏复律除颤器治疗的影响。
Yonsei Med J. 2020 Nov;61(11):942-950. doi: 10.3349/ymj.2020.61.11.942.
2
A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function Clinics.一项基于人群的心脏功能诊所患者设备适用性、使用情况及未植入原因的研究。
CJC Open. 2019 Jun 7;1(4):173-181. doi: 10.1016/j.cjco.2019.05.002. eCollection 2019 Jul.
3
Epidemiology of Sudden Cardiac Death: Global and Regional Perspectives.
心脏性猝死的流行病学:全球及区域视角
Heart Lung Circ. 2019 Jan;28(1):6-14. doi: 10.1016/j.hlc.2018.08.026. Epub 2018 Sep 24.
4
Improving the utilization of implantable cardioverter defibrillators for sudden cardiac arrest prevention (Improve SCA) in developing countries: Clinical characteristics and reasons for implantation refusal.提高发展中国家植入式心脏复律除颤器预防心脏骤停的利用率(改善心脏骤停情况):临床特征及植入拒绝原因
Pacing Clin Electrophysiol. 2018 Dec;41(12):1619-1626. doi: 10.1111/pace.13526. Epub 2018 Oct 31.
5
Statistics on the use of cardiac electronic devices and interventional electrophysiological procedures in Africa from 2011 to 2016: report of the Pan African Society of Cardiology (PASCAR) Cardiac Arrhythmias and Pacing Task Forces.2011 年至 2016 年非洲心脏电子设备和介入电生理程序使用情况统计:泛非心脏病学会(PASCAR)心律失常和起搏工作组报告。
Europace. 2018 Sep 1;20(9):1513-1526. doi: 10.1093/europace/eux353.
6
Prediction and Prevention of Sudden Cardiac Death.心脏性猝死的预测与预防
Card Electrophysiol Clin. 2017 Dec;9(4):631-638. doi: 10.1016/j.ccep.2017.07.012.
7
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
Circulation. 2018 Sep 25;138(13):e210-e271. doi: 10.1161/CIR.0000000000000548.
8
Primary Prevention of Sudden Cardiac Death With Device Therapy in Urban and Rural Populations.城乡人群中使用器械治疗对心脏性猝死的一级预防
Can J Cardiol. 2017 Apr;33(4):437-442. doi: 10.1016/j.cjca.2016.10.020. Epub 2017 Jan 17.
9
Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program.心力衰竭住院患者植入式心脏复律除颤器咨询与使用中的性别及种族/民族差异:来自“遵循指南-心力衰竭”项目的发现
Circulation. 2016 Aug 16;134(7):517-26. doi: 10.1161/CIRCULATIONAHA.115.021048. Epub 2016 Aug 4.
10
Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis.心力衰竭患者植入式心脏复律除颤器的使用不足——心脏性猝死预防的现状
Indian Pacing Electrophysiol J. 2015 Apr 1;15(1):20-9. doi: 10.1016/S0972-6292(16)30838-5. eCollection 2015 Jan-Feb.